All eyes on tech earnings All eyes on tech earnings All eyes on tech earnings

All eyes on tech earnings

Equities 4 minutes to read

Summary:  Risky assets followed the Fed, pushing higher overnight, and setting a firm positive lead for Asia as the Feds ultra-dovish message crushed yields and propelled stocks and gold higher. The Fed maintaining the mantra to do whatever it takes to support the economy and hinting at further action in preparing for the worst, supporting the return of the perpetually bid growth/momentum trade overnight and green lighting yield hunting behaviour, with little regard for economic realities.

Healthcare and technology stocks the biggest gainers on the ASX 200, again following the dovish signals from the Fed, with rates set to remain low for an extended period. Music to the ears of seemingly infinity bound momentum and growth stocks, with the earnings duration pathways whose valuations are boosted by record low rates set to extend for years to come.

However, the “whatever it takes” boost petering out and US futures trading lower, dollar bid smalls with a slight risk off tone creeping into the afternoon session as investors weighed the ever-mounting COVID-19 toll on the global economy, congressional gridlock on the next stimulus bill and the earnings releases from tech titans, Apple, Amazon and Alphabet tonight. Higher cases in Victoria, Tokyo and record deaths in Texas also injecting a dose of reality into the frenzy precipitated by central bank’s bid to remain accommodative at all costs and detach asset prices from reality. This liquidity induced, frenzied behaviour in full view as Robinhood data shows daytraders stampeding into Kodak stock. According to Robintrack data, around 43,000 Robinhood users have added Kodak to their accounts in some form over the past 24 hours as speculation on virus cures runs rife. At one stage overnight, the stock was up almost 700%.

Although the Fed was the big story overnight, Chairman Powell offered up very few surprises, with no major changes to the policy stance and post meeting statement. However, what was offered was a decisive reiteration of current policy settings and a clear commitment that monetary policy will remain expansionary with Powell’s commentaries remaining as dovish as possible without the addition of new “tools”. Powell whilst stopping short of directly tying forward guidance to a specific outcome, hinted at the readiness to strengthen forward guidance shifting to an outright measure down the track, which would include tying future rate increases explicitly to actual inflation reaching/overshooting 2%. The Fed chair was also keen to emphasise the enormous degree of uncertainty that remains with respect to the economy and tie the path of policy to the pandemic and unknown virus outcomes. Essentially forewarning market participants that the Fed is ready to take further action if necessary, and has plenty of room to manoeuvre should the need arise.

Tonight’s 2Q GDP read is likely to confirm a collapse in the US economy of epic proportions at the hands of the global pandemic. However, although the read will no doubt grab headlines, the data is largely backward looking and with the virus resurgence ruling present outcomes the high frequency data will provide a better read on the state of the US economy. Again overnight the Fed chair was quick to point out that this high frequency data has stalled with the resurgence of the virus and recovery momentum appears to faltering, as we have previously noted.

 The true directional focus for risk assets will however most likely come from the mega cap tech earnings. Speculative excesses in technology stocks which have led the charge in the melt up off the March lows have embedded some solid expectations about these companies, which given lofty expectations must be met. With concentration another risk factor, as large cap tech now accounts for almost 40% of the S&P 500, the onus on delivery for broad market sentiment is large.


The Saxo Bank Group entities each provide execution-only service and access to Analysis permitting a person to view and/or use content available on or via the website. This content is not intended to and does not change or expand on the execution-only service. Such access and use are at all times subject to (i) The Terms of Use; (ii) Full Disclaimer; (iii) The Risk Warning; (iv) the Rules of Engagement and (v) Notices applying to Saxo News & Research and/or its content in addition (where relevant) to the terms governing the use of hyperlinks on the website of a member of the Saxo Bank Group by which access to Saxo News & Research is gained. Such content is therefore provided as no more than information. In particular no advice is intended to be provided or to be relied on as provided nor endorsed by any Saxo Bank Group entity; nor is it to be construed as solicitation or an incentive provided to subscribe for or sell or purchase any financial instrument. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. As such no Saxo Bank Group entity will have or be liable for any losses that you may sustain as a result of any investment decision made in reliance on information which is available on Saxo News & Research or as a result of the use of the Saxo News & Research. Orders given and trades effected are deemed intended to be given or effected for the account of the customer with the Saxo Bank Group entity operating in the jurisdiction in which the customer resides and/or with whom the customer opened and maintains his/her trading account. Saxo News & Research does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Bank Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication under relevant laws.

Please read our disclaimers:
- Notification on Non-Independent Investment Research (
- Full disclaimer (

Saxo Markets
40 Bank Street, 26th floor
E14 5DA
United Kingdom

Contact Saxo

Select region

United Kingdom
United Kingdom

Trade Responsibly
All trading carries risk. To help you understand the risks involved we have put together a series of Key Information Documents (KIDs) highlighting the risks and rewards related to each product. Read more
Additional Key Information Documents are available in our trading platform.

Saxo Markets is a registered Trading Name of Saxo Capital Markets UK Ltd (‘SCML’). SCML is authorised and regulated by the Financial Conduct Authority, Firm Reference Number 551422. Registered address: 26th Floor, 40 Bank Street, Canary Wharf, London E14 5DA. Company number 7413871. Registered in England & Wales.

This website, including the information and materials contained in it, are not directed at, or intended for distribution to or use by, any person or entity who is a citizen or resident of or located in the United States, Belgium or any other jurisdiction where such distribution, publication, availability or use would be contrary to applicable law or regulation.

It is important that you understand that with investments, your capital is at risk. Past performance is not a guide to future performance. It is your responsibility to ensure that you make an informed decision about whether or not to invest with us. If you are still unsure if investing is right for you, please seek independent advice. Saxo Markets assumes no liability for any loss sustained from trading in accordance with a recommendation.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the U.S. and other countries. App Store is a service mark of Apple Inc. Android is a trademark of Google Inc.

©   since 1992